ÇѸ²´ëÇб³¼º½Éº´¿ø

±èÁÂ°æ ±³¼ö

  • Áø·á°ú ½ÅÀå³»°ú

Àü¹®Áø·áºÐ¾ß

»ç±¸Ã¼ ½Å¿°, ¸¸¼º½ÅºÎÀü, Ç÷¾×Åõ¼®, º¹¸·Åõ¼®

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2026-01-05 ~ 2026-01-10)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿Ü·¡Áø·á¿Ü·¡Áø·á¿Ü·¡Áø·á
¿ÀÈÄ ¿Ü·¡Áø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ¹Ú»ç

ÇѸ²´ëÇб³ Àǰú´ëÇÐ ¼®»ç

ÇѸ²´ëÇб³ Àǰú´ëÇÐ ¼ö¼® Á¹¾÷

°æ·Â

°æ·Â

ÇѸ²´ëÇб³¼º½Éº´¿ø ³»°ú Àü°øÀÇ

¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø ½ÅÀå³»°ú ÀüÀÓÀÇ

¹Ì±¹ University of San Diego, Immunology ¿¬¼ö

´ëÇѽÅÀåÇÐȸ Kidney Research Clinical Practice ÆíÁýÀ§¿ø

ÇѸ²Áß°³ÀÇÇבּ¸¼Ò ¼ÒÀå

±¸) ´ëÇѽÅÀåÇÐȸ ºÎÃѹ« ÀÌ»ç

Çö) ´ëÇѽÅÀåÇÐȸ Åõ¼®ÀÌ»ç

ÇѸ²´ëÇб³¼º½Éº´¿ø ½ÅÀå³»°ú ±³¼ö

ÇÐȸȰµ¿

ÇÐȸȰµ¿

¼¼°è½ÅÀåÇÐȸ(International Society of Nephrology, ISN) Á¤È¸¿ø

´ëÇѽÅÀåÇÐȸ Á¤È¸¿ø

´ëÇÑ ÁßÀç½ÅÀåÇבּ¸È¸ Á¤È¸¿ø

³í¹®

Galectin-3 as a prognostic biomarker in haemodialysis patients with preserved or mildly reduced ejection fraction (CLINICAL KIDNEY JOURNAL)

Risk of pancreatic cancer according to glycemic status in nonalcoholic fatty liver disease: a nationwide cohort study (SCIENTIFIC REPORTS)

Risk of hepatocellular carcinoma according to body mass index and waist circumference in nonalcoholic fatty liver disease (WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY)

Burden of End-Stage Kidney Disease by Type 2 Diabetes Mellitus Status in South Korea: A Nationwide Epidemiologic Study (DIABETES & METABOLISM JOURNAL)

Impact of Peritoneal Neutrophil Extracellular Traps on Peritoneal Characteristics and Technical Failure in Patients Undergoing Peritoneal Dialysis (AMERICAN JOURNAL OF NEPHROLOGY)

Impact of Peritoneal Neutrophil Extracellular Traps on Peritoneal Characteristics and Technical Failure in Patients Undergoing Peritoneal Dialysis / ^^¿µ¹® Á¦¸ñÀ» ¹Ýµå½Ã ±âÀçÇϽñ⠹ٶø´Ï´Ù. (Am J Nephrol)

Development of deep learning algorithm for detecting dyskalemia based on electrocardiogram / ^^¿µ¹® Á¦¸ñÀ» ¹Ýµå½Ã ±âÀçÇϽñ⠹ٶø´Ï´Ù. (Scientific Reports)

Impact of Fat Mass on Osteoporosis, Sarcopenia, and Osteosarcopenia in Peritoneal Dialysis Patients / ^^¿µ¹® Á¦¸ñÀ» ¹Ýµå½Ã ±âÀçÇϽñ⠹ٶø´Ï´Ù. (Am J Nephrol)

Impact of age on eGFR dynamics following sodium-glucose cotransporter 2$$inhibitor therapy: A real-world study / ^^¿µ¹® Á¦¸ñÀ» ¹Ýµå½Ã ±âÀçÇϽñ⠹ٶø´Ï´Ù. (Diabetic Research Clinical Practice)

Mediating effect of vascular calcification in galectin-3-related mortality in hemodialysis patients / ^^¿µ¹® Á¦¸ñÀ» ¹Ýµå½Ã ±âÀçÇϽñ⠹ٶø´Ï´Ù. (Scientific Reports)

°Ç°­¸Å°ÅÁø